17-Oxime ethers of oxidized ecdysteroid derivatives modulate oxidative stress in human brain endothelial cells and dose-dependently might protect or damage the blood-brain barrier.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 09 08 2023
accepted: 07 01 2024
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: epublish

Résumé

20-Hydroxyecdysone and several of its oxidized derivatives exert cytoprotective effect in mammals including humans. Inspired by this bioactivity of ecdysteroids, in the current study it was our aim to prepare a set of sidechain-modified derivatives and to evaluate their potential to protect the blood-brain barrier (BBB) from oxidative stress. Six novel ecdysteroids, including an oxime and five oxime ethers, were obtained through regioselective synthesis from a sidechain-cleaved calonysterone derivative 2 and fully characterized by comprehensive NMR techniques revealing their complete 1H and 13C signal assignments. Surprisingly, several compounds sensitized hCMEC/D3 brain microvascular endothelial cells to tert-butyl hydroperoxide (tBHP)-induced oxidative damage as recorded by impedance measurements. Compound 8, containing a benzyloxime ether moiety in its sidechain, was the only one that exerted a protective effect at a higher, 10 μM concentration, while at lower (10 nM- 1 μM) concentrations it promoted tBHP-induced cellular damage. Brain endothelial cells were protected from tBHP-induced barrier integrity decrease by treatment with 10 μM of compound 8, which also mitigated the intracellular reactive oxygen species production elevated by tBHP. Based on our results, 17-oxime ethers of oxidized ecdysteroids modulate oxidative stress of the BBB in a way that may point towards unexpected toxicity. Further studies are needed to evaluate any possible risk connected to dietary ecdysteroid consumption and CNS pathologies in which BBB damage plays an important role.

Identifiants

pubmed: 38386637
doi: 10.1371/journal.pone.0290526
pii: PONE-D-23-25409
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0290526

Informations de copyright

Copyright: © 2024 Vágvölgyi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Máté Vágvölgyi (M)

Institute of Pharmacognosy, University of Szeged, Szeged, Hungary.

Dávid Laczkó (D)

Institute of Pharmacognosy, University of Szeged, Szeged, Hungary.

Ana Raquel Santa-Maria (AR)

Institute of Biophysics, HUN-REN Biological Research Centre, Szeged, Hungary.
Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, United States of America.

Judit P Vigh (JP)

Institute of Biophysics, HUN-REN Biological Research Centre, Szeged, Hungary.
Doctoral School of Biology, University of Szeged, Szeged, Hungary.

Fruzsina R Walter (FR)

Institute of Biophysics, HUN-REN Biological Research Centre, Szeged, Hungary.

Róbert Berkecz (R)

Institute of Pharmaceutical Analysis, University of Szeged, Szeged, Hungary.

Mária A Deli (MA)

Institute of Biophysics, HUN-REN Biological Research Centre, Szeged, Hungary.

Gábor Tóth (G)

NMR Group, Department of Inorganic and Analytical Chemistry, Budapest University of Technology and Economics, Budapest, Hungary.

Attila Hunyadi (A)

Institute of Pharmacognosy, University of Szeged, Szeged, Hungary.
Interdisciplinary Centre of Natural Products, University of Szeged, Szeged, Hungary.
HUN-REN-SZTE Biologically Active Natural Products Research Group, Szeged, Hungary.

Classifications MeSH